Stem cell research promises to provide new therapies, preventive measures and even cures for some major human diseases and disorders. But some policymakers, like many Americans, have deep misgivings about the use of human embryonic tissue for this purpose. A panel talks about the therapeutic potential of stem cells, the ethical issues raised by the work, and federal funding for the research.

Guests

  • Dr. Robert Goldstein chief scientific officer for the Juvenile Diabetes Foundation International
  • Dr. David Prentice of Do No Harm: Coalition of Americans for Research Ethics
  • Rick Weiss science reporter for "The Washington Post"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 31 2014Iraqi Kurdish soldiers and Syrian rebels join the battle against ISIS in Kobani, the search continues for missing students in Mexico, and the last U.S. Marines pull out of a key base in Afghanistan. A panel of journalists joins guest host Susan Page for a conversation about the week's top international stories.

Friday News Roundup – Domestic

Friday, Oct 31 2014Last-minute campaigning with just days to go before the midterm elections. The Federal Reserve ends its bond-buying program. And debate continues over Ebola quarantines in the U.S. A panel of journalists joins guest host Susan Page for a conversation about the week's top national stories.